News Release Archive
InNOVAcorp--REGULATORY ISSUES SEMINAR ----------------------------------------------------------------- Regulatory issues affecting Nova Scotia's emerging biotechnology companies are the topic of a biotechnology training seminar hosted by the Biotechnology Working Groups (NS) Tuesday, March 25, in Halifax. Two representatives from the United States Food and Drug Administration (US FDA) will discuss regulatory issues and provide an opportunity the following day for one-on-one consultation with interested companies. The training seminar will discuss key biotechnology issues such as U.S. FDA pre-market requirements, good manufacturing practices, new import/export requirements, biological products, medical devices, and pharmaceuticals. This event has been coordinated by Industry Canada and the Biotechnology Working Groups. The Biotechnology Working Groups (NS) is an industry association representing companies working in marine research, food, pharmaceuticals and diagnostic areas of the bio-industry sector of Nova Scotia. The working group has two clusters of members - one in the Halifax-metro area and another in the Annapolis Valley. The biotechnology working groups have an office at InNOVAcorp - Nova Scotia's crown corporation focused on assisting Nova Scotia businesses to commercialize their technology-based products and services. "Our focus is to actively pursue commercialization of advanced biological technology in this province." We are here to share information, and make connections for our companies." said group chair Dr. Mike Winther. "This seminar is a valuable opportunity for our members. Marine research, food, pharmaceuticals and medical devices - these are areas Nova Scotia companies are working in, and they will need to understand the FDA regulations to do business in the United States." The session March 25th will be held from 9:00 a.m. - 5:00 p.m. at the World Trade and Convention Centre, Highland Suite six. Sponsorship for the event is provided by the Business Development Bank of Canada (BDC), the Canadian Institute of Biotechnology and the Nova Scotia Economic Renewal Agency. The Biotechnology Working Groups association is funded by the Canadian Institute of Biotechnology and the Canada/Nova Scotia COOPERATION Agreement managed by the Atlantic Canada Opportunities Agency (ACOA) and InNOVAcorp. -30- Contact: Janet Colpitts 902-424-8670 ext. 129 trp Mar. 20, 1997 - 8:30 a.m.